BLACK WEEKSΦιαλίδια −15% · κιτ −10% · υπόλοιπα −5%με κωδικόΔωρεάν αποστολή εντός Γερμανίας από €200

Αυτή η σελίδα μεταφράστηκε αυτόματα και μπορεί να περιέχει λάθη. Είστε φυσικός ομιλητής; Θα χαρούμε να λάβουμε τα σχόλια και τις διορθώσεις σας.Στείλτε σχόλια

The Peptide Desk The Peptide Desk
Cerebrolysin, φωτογραφία προϊόντος
Cognition

Cerebrolysin

Cognition

  • Αποστολή από τη Γερμανία

Παραγγελία

Τιμή μονάδας - Δωρεάν αποστολή εντός Γερμανίας από 200 € κατά τις Black Weeks
  • DHL με παρακολούθηση
  • Διακριτική συσκευασία

4.6 στα 5 στο Trustpilot73 αξιολογήσεις

Με μια ματιά

Cerebrolysin σε αριθμούς

Τα βασικά στοιχεία από το λεξικό μας.

Πλήρες λήμμα λεξικού
Class
Neurotrophic peptide mixturebrain extract
Form
Lyophilisate, 60mg/vial6-pack = 360mg
Sizes
60mg/6vials1 size in the shop
  1. Randomized study in acute ischemic stroke (CASTA) (opens in a new tab)

    Heiss et al., Stroke, 2012
  2. Cochrane review on vascular dementia (opens in a new tab)

    Cui et al., Cochrane Database of Systematic Reviews, 2019

Γνώσεις

Όλα για το Cerebrolysin

Καλό να έχετε

Τι χρειάζεστε μαζί

Το βακτηριοστατικό νερό προστίθεται αυτόματα στο καλάθι σας. Σύριγγες και μαντηλάκια με ένα κλικ.

Σύριγγες ινσουλίνης

10 τεμ. · 5.50 €

Μαντηλάκια οινοπνεύματος

50 τεμ. · 10 €

Πόσο νερό;

Μονάδες στη σύριγγα για το μέγεθος του φιαλιδίου σας.

Άνοιγμα υπολογιστή →

FAQ

Συχνές ερωτήσεις

Πηγές για κάθε απάντηση: λήμμα λεξικού

Έχετε ακόμη κάποια ερώτηση;

Γράψτε μας, η ομάδα μας θα σας βοηθήσει.

Is Cerebrolysin approved?

A Cochrane review describes Cerebrolysin as widely used for stroke in Russia, Eastern Europe, China and other Asian countries. Many of the manufacturer's trials are registered as phase 4. This powder is a research product, the trials used the ready-made liquid solution.

What is in Cerebrolysin?

A mixture made in a standardised process from small peptides under 10 kDa and free amino acids from pig brain. It has no single receptor but is meant to act like the body's own nerve growth factors.

What did the large stroke trial CASTA show?

1,070 people with acute stroke received Cerebrolysin or saline for 10 days. There was no difference on the primary endpoint. In severely affected patients a post hoc analysis showed 10.5 percent deaths with Cerebrolysin and 20.2 percent with placebo. The authors see this as a signal that still needs confirmation.

What is known in vascular dementia?

A Cochrane review with six trials and 597 participants found a benefit for thinking and overall condition. The evidence is very low certainty though, the trials are at high risk of bias and, where known, were supported by the manufacturer. The authors think the effect may be too small to matter in daily life.

Does it help recovery after stroke or brain injury?

In the CARS trial with rehab over 21 days arm function after 90 days was clearly better than on placebo, but the trial was small and exploratory. After moderate to severe brain injury CAPTAIN II found a small to medium advantage across many measures. Both need to be confirmed in larger trials.

Which side effects are known?

In acute stroke Cerebrolysin changed neither mortality nor the number of all serious adverse events according to the Cochrane review, but non-fatal serious adverse events were more common than on placebo (relative risk 2.39). In an Alzheimer's trial agitation, dizziness and headache were common.

Do the trials transfer to this product?

Only to a limited extent. In the trials the ready-made liquid solution was given as an infusion into a vein, over some days to weeks. This product is a freeze-dried powder that the entry describes for subcutaneous or intramuscular use. There are no data on this form.

Σχετικά προϊόντα

Σχετικά προϊόντα